SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about press release

19 Jun 2026 Evaluate
Hester Biosciences has informed that it enclosed a copy of each newspaper clipping of the advertisement published on 19 June 2026 on Notice of 39th Annual General Meeting, Dividend details and e-voting information to Members, in Ahmedabad edition of the following newspapers: Financial Express (English), and Financial Express (Gujarati).

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2193.45 32.00 (1.48%)
01-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1865.95
Dr. Reddys Labs. 1339.35
Cipla 1456.95
Zydus Lifesciences 1108.85
Lupin 2396.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: